The effect of synbiotic supplementation in systemic lupus erythematosus patients
Phase 2
Recruiting
- Conditions
- Systemic lupus erythematosus.Systemic lupus erythematosus (SLE)
- Registration Number
- IRCT20240510061723N1
- Lead Sponsor
- Ardabil University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 76
Inclusion Criteria
Definitive diagnosis of SLE
Age above 18 years
Exclusion Criteria
Taking antibiotics
pregnancy
breastfeeding
Uncontrolled blood pressure
Suffering from other autoimmune diseases
diabetes
Severe kidney and liver disease
Life-threatening SLE including lupus nephritis and CNS involvement
Lupus vasculitis
peritonitis
severe hemolysis
Platelets less than 40,000
Endocarditis
Alveolar hemorrhage
Lupus pneumonia
OCP intake
Taking supplements containing antioxidants or omega-3 in the last month
Sensitivity to synbiotics
Smoking and alcohol consumption
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method